Joseph Mark Firriolo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 6 | 2022 | 1264 | 0.720 |
Why?
|
| Osteogenesis, Distraction | 1 | 2023 | 232 | 0.720 |
Why?
|
| Jejunum | 2 | 2019 | 474 | 0.680 |
Why?
|
| Caustics | 1 | 2019 | 33 | 0.650 |
Why?
|
| Esophageal Atresia | 2 | 2019 | 225 | 0.640 |
Why?
|
| Burns, Chemical | 1 | 2019 | 123 | 0.600 |
Why?
|
| Ketorolac | 1 | 2018 | 95 | 0.590 |
Why?
|
| Surgery, Plastic | 2 | 2020 | 652 | 0.540 |
Why?
|
| Surgical Flaps | 4 | 2023 | 1678 | 0.530 |
Why?
|
| Breast | 9 | 2022 | 1946 | 0.530 |
Why?
|
| Pressure Ulcer | 1 | 2018 | 155 | 0.530 |
Why?
|
| Orbital Fractures | 1 | 2017 | 108 | 0.530 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 413 | 0.470 |
Why?
|
| Nausea | 1 | 2017 | 680 | 0.460 |
Why?
|
| Vomiting | 1 | 2017 | 647 | 0.450 |
Why?
|
| Hematoma | 1 | 2018 | 766 | 0.440 |
Why?
|
| Esophagus | 1 | 2019 | 1037 | 0.420 |
Why?
|
| Hypertrophy | 4 | 2022 | 561 | 0.370 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 2223 | 0.350 |
Why?
|
| Quality of Life | 7 | 2022 | 13462 | 0.340 |
Why?
|
| Gynecomastia | 2 | 2022 | 87 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2269 | 0.310 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 1771 | 0.290 |
Why?
|
| Umbilicus | 1 | 2023 | 37 | 0.210 |
Why?
|
| Telemedicine | 1 | 2020 | 3105 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3101 | 0.200 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2023 | 138 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3224 | 0.200 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2022 | 116 | 0.190 |
Why?
|
| Self Concept | 2 | 2017 | 1038 | 0.180 |
Why?
|
| Titanium | 1 | 2023 | 490 | 0.180 |
Why?
|
| Progestins | 1 | 2022 | 300 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.170 |
Why?
|
| Bone Screws | 1 | 2023 | 533 | 0.170 |
Why?
|
| Mandible | 1 | 2023 | 746 | 0.150 |
Why?
|
| Polydactyly | 1 | 2018 | 57 | 0.150 |
Why?
|
| Adolescent | 14 | 2022 | 88781 | 0.140 |
Why?
|
| Acrocephalosyndactylia | 1 | 2018 | 92 | 0.140 |
Why?
|
| Transplantation, Autologous | 1 | 2022 | 2120 | 0.140 |
Why?
|
| Young Adult | 12 | 2022 | 59852 | 0.130 |
Why?
|
| Diplopia | 1 | 2017 | 217 | 0.130 |
Why?
|
| Adipocytes | 1 | 2022 | 1193 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2020 | 65180 | 0.110 |
Why?
|
| Child | 11 | 2023 | 80499 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1183 | 0.110 |
Why?
|
| Osteotomy | 1 | 2018 | 834 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2018 | 1470 | 0.100 |
Why?
|
| Body Image | 1 | 2017 | 645 | 0.100 |
Why?
|
| Salvage Therapy | 1 | 2018 | 1272 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 2240 | 0.100 |
Why?
|
| Humans | 23 | 2023 | 765734 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2022 | 81457 | 0.090 |
Why?
|
| Overweight | 1 | 2022 | 2443 | 0.090 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 3478 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4850 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3313 | 0.090 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 1273 | 0.090 |
Why?
|
| Obesity | 3 | 2022 | 13079 | 0.080 |
Why?
|
| Recurrence | 2 | 2020 | 8498 | 0.080 |
Why?
|
| Female | 15 | 2022 | 395961 | 0.080 |
Why?
|
| Linear Models | 1 | 2018 | 5876 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39180 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1663 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2019 | 42468 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2020 | 1816 | 0.060 |
Why?
|
| Male | 8 | 2022 | 363585 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7875 | 0.050 |
Why?
|
| Infant | 3 | 2019 | 36363 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3835 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15390 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2020 | 5946 | 0.040 |
Why?
|
| Connective Tissue Cells | 1 | 2018 | 50 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2018 | 511 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 14745 | 0.040 |
Why?
|
| Finger Phalanges | 1 | 2018 | 41 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15749 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 704 | 0.030 |
Why?
|
| Estrogens | 1 | 2022 | 1529 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1208 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2022 | 54795 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 1336 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20667 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21053 | 0.030 |
Why?
|
| Adult | 6 | 2023 | 222974 | 0.020 |
Why?
|
| United States | 1 | 2020 | 72898 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26284 | 0.020 |
Why?
|
| Self Report | 1 | 2020 | 3772 | 0.020 |
Why?
|
| Patient Selection | 1 | 2020 | 4254 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3948 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 41631 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 4862 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22224 | 0.010 |
Why?
|
| Length of Stay | 1 | 2018 | 6487 | 0.010 |
Why?
|
| Risk Factors | 2 | 2022 | 74831 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18972 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10428 | 0.010 |
Why?
|
| Mental Health | 1 | 2017 | 3272 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18375 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11641 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 13044 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10846 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 222903 | 0.000 |
Why?
|